Matinas BioPharma's Multi-Million Share Sale and Lock-Up Deal

TipRanksApr 5 19:12

Matinas BioPharma Prices $10 Million Registered Direct Offering

BEDMINSTER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE:MTNB) ("Matinas BioPharma" or the "Company"), a clinical-stage biopharmaceutical company focused on delivering groundbreaking

GlobeNewswireApr 3 20:30

Matinas BioPharma (MTNB) Gets a Buy From Maxim Group

TipRanksApr 2 22:35

12 Health Care Stocks Moving In Monday's After-Market Session

GainersOpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. The market value of their outstanding shares is at $7.4 million. Galecto (NASDAQ:GLTO) shares in

BenzingaApr 2 04:31

Earnings Call Summary | Matinas BioPharma(MTNB.US) Q4 2023 Earnings Conference

The following is a summary of the Matinas BioPharma Holdings, Inc. (MTNB) Q4 2023 Earnings Call Transcript:Financial Performance:Matinas BioPharma reported a revenue of $1.1 million for 2023, primaril

Futu NewsMar 29 12:05 · Conference Call

Matinas BioPharma Updates Presentation for Investor Outreach

TipRanksMar 28 21:13